Statistical analyses revealed that NOX4 expression was strongly correlated with the clinical stage and tumor-nodule-metastasis (TNM) classification in NSCLC patients both of adenocarcinoma and squamous carcinoma (Fig. 1C). The gene discussed is NOX4; the disease is squamous cell carcinoma.